On the contrary, fibroblast‐specific GRK5 KO mice showed reduced fibrosis and improved cardiac function at 4‐week post‐MI [26], implying that GRK5 in fibroblasts/myofibroblasts is a risk molecule that worsens cardiac function in the late phase of MI. The gene discussed is GRK5; the disease is myocardial infarction.